Predictive and prognostic biomarker discovery for brain disorders
Slight modifications to glycoproteins reveal critical insights into disease onset, state, and progression, making them a wellspring for biomarker discovery.
Klaus Pantel and Christoffer Beghardt will discuss advances in early cancer biomarker detection and its clinical implications.
In this webinar, experts will discuss new approaches to identify small therapeutic candidates targeting diabetes and Alzheimer’s disease.